Dongwha Pharm, Stock Price 23,800 KRW (-4.61%)... Bulletin Board 'Bustling'

At this time, posts about Dongwha Pharm are rapidly increasing on portals and securities communities. Today, foreigners have net sold 30,000 shares of Dongwha Pharm, and institutions have net sold 1,000 shares, according to preliminary estimates. Dongwha Pharm is known as a pharmaceutical manufacturer and seller (including Gas Hwal Myeong Su, Fusidin, etc.).

As of 12:30 PM on the 13th, Dongwha Pharm's stock price is 23,800 KRW, down 4.61% from the previous day, with a trading volume of 1,521,012 shares, which is 39.8% of the 5-day average trading volume. On August 12, Dongwha Pharm became a market issue with the news "DW2008 COVID-19 treatment entering Phase 2 clinical trials ↑".

In addition to Dongwha Pharm, posts by investors are also surging for Deokyang Industry (024900), SK Discovery U (006125), and Beomyang Geonyeong (002410).

※Source: AI Investment Assistant AI Lassi Ro

※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.